The average one-year price target for Vertex (BIT:1VERX) has been revised to €17.65 / share. This is a decrease of 25.85% from the prior estimate of €23.80 dated February 3, 2026. The price target is ...
View Vertex Pharmaceuticals Incorporated VRTX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Investors were snapping up shares of fintech stock Vertex (NASDAQ: VERX) on Thursday. That followed a rather glowing research update from an analyst at a prominent investment bank. With that in its ...
Hosted on MSN
Why Vertex Pharmaceuticals (VRTX) stock is up today
Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and ...
Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology firm that discovers, develops, and commercializes transformative medicines for serious diseases, with a particular focus on ...
View Vertex, Inc. Class A VERX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results